ILA Island Pharmaceuticals Limited
Pharmaceuticals, Biotechnology & Life Sciences
Next annual general meeting
Tuesday 24 November 2026
01:00pm · New South Wales · Announced
The company has announced this date. The notice of meeting, with the agenda, is due at least 28 days before.
Last AGM voting results
Results of the AGM held Thursday 9 October 2025.
| # | Resolution | For | Against | Result |
|---|---|---|---|---|
| 1 | Adoption of Remuneration Report | 99.79% | 0.21% | carried |
| 2 | Election of Jason Carroll as Director | 100.00% | 0.00% | carried |
| 3 | Approval of increased placement capacity | 94.95% | 5.05% | carried |
| 4 | Ratification of issue of First Tranche Shares | 97.84% | 2.16% | carried |
| 5 | Ratification of issue of S3 Consortium Shares | 97.87% | 2.13% | carried |
| 6 | Approval of issue of Shares to Christopher Ntoumenopoulos | 87.00% | 13.00% | carried |
| 7 | Approval of issue of Shares to Phillip Lynch | 91.91% | 8.09% | carried |
| 8 | Approval of issue of Shares to David Foster | 99.50% | 0.50% | carried |
| 9 | Approval of issue of the Ntoumenopoulos Options to Christopher Ntoumenopoulos | 86.69% | 13.31% | carried |
| 10 | Approval of issue of the Ntoumenopoulos Performance Options to Christopher Ntoumenopoulos | 84.58% | 15.42% | carried |
| 11 | Approval of issue of the Foster Performance Options to David Foster | 99.48% | 0.52% | carried |
| 12 | Approval of issue of Carroll Performance Options to Jason Carroll | 99.21% | 0.79% | carried |
| 13 | Approval of issue of Carroll Options to Jason Carroll | 99.10% | 0.90% | carried |
| 14 | Approval to issue Advisor Options | 94.35% | 5.65% | carried |
| 15 | Approval of issue of Lynch Options to Phillip Lynch | 54.63% | 45.37% | carried |
Protest vote: 20% or more against, or not carried.